Article
Antisense-Mediated Skipping of Dysferlin Exons in Control and Dysferlinopathy Patient-Derived Cells.
Nucleic acid therapeutics - 1 Apr 2020
Verwey Nisha, Gazzoli Isabella, Krause Sabine, Mamchaoui Kamel, Mouly Vincent, Aartsma-Rus Annemieke
Abstract excerpt
Dysferlinopathies encompass a spectrum of progressive muscular dystrophies caused by the lack of dysferlin due to missense mutations in the dysferlin gene or mutations causing premature truncation of protein translation. Dysferlin is a modular protein, and dysferlins lacking one or more repetitive domains have been shown to retain functionality. As such, antisense-mediated exon skipping has been proposed as a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
